HomeNewsIndia NewsAnalog Devices Foundation Donates $500,000 for COVID-19 Vaccine Development and Testing

Analog Devices Foundation Donates $500,000 for COVID-19 Vaccine Development and Testing

Analog Devices, Inc. (Nasdaq: ADI) and The Analog Devices Foundation, ADI’s charitable arm that advances its mission to engineer a more sustainable future, announced  its recent $500,000 donation to fund research at Massachusetts General Hospital (MGH)’s Vaccine & Immunotherapy Center (VIC), directed by Dr. Mark Poznansky MD, PhD.

The donation will directly support the VIC’s work to develop a vaccine and novel point of care testing technologies for COVID-19, which is critical to start opening up the economy and increase safety of healthcare workers and their patients. Analog Devices and the VIC are supporting a trial to develop and deploy two new tests to identify and confirm which individuals have a detectable immune response to COVID-19 and are virus negative. ADI and the VIC will also seek ways to leverage ADI’s sensing technologies to develop rapid care tests and real-time remote vital sign monitoring for COVID-19 patients in quarantine.

“Analog Devices is proud to work with Massachusetts General Hospital’s Vaccine & Immunotherapy Center as it works tirelessly to discover the testing solutions required to identify COVID-19 in individuals and slow the spread of the virus,” said Vincent Roche, President and CEO of ADI. “There is no better teammate in this fight than this prestigious medical research institution and we look forward to working together to apply sensing technology to testing and monitoring for COVID-19 patients.”

“We know that many individuals infected with COVID-19 have still not been able to access testing to confirm the diagnosis,” said Dr. Poznansky, MD, PhD, and Associate Professor of Medicine at Harvard Medical School and Attending Physician in General and Transplant Infectious Diseases at MGH. “Additionally, there are many others who might have been infected but are unaware because they were asymptomatic. Confirming immunity and viral negativity will be critical to both beginning to help open up key sectors of society and identifying those that can relatively safely interact amongst others and those who should remain in quarantine.”

The MGH VIC was founded in 2008 to accelerate the translation of laboratory discoveries  into new, safe, and broadly applicable cost-effective vaccines and therapies to prevent and cure various forms of cancer, infectious and immune mediated diseases. VIC has nine medical products currently in development and three have entered human testing.

For more information, visit www.analog.com

ELE Times Bureau
ELE Times Bureauhttps://www.eletimes.ai/
ELE Times provides a comprehensive global coverage of Electronics, Technology and the Market. In addition to providing in depth articles, ELE Times attracts the industry’s largest, qualified and highly engaged audiences, who appreciate our timely, relevant content and popular formats. ELE Times helps you build awareness, drive traffic, communicate your offerings to right audience, generate leads and sell your products better.

Related News

Must Read

Top 10 Advanced IC Substrate Manufacturers in 2026: Leading Companies Powering the AI Semiconductor Revolution

A combination of Artificial Intelligence (AI), High-Performance Computing (HPC),...

Cyient DLM and Hindustan Shipyard Sign MoU to Advance Indigenous Maritime and Defence Electronics

Partnership to Focus on Indigenous Electronics, Advanced Manufacturing and...

Driving Motion Precision: How Physical AI is Converting Data into Action

Autonomous manufacturing is entering a new phase where robotics,...

GÖPEL Electronic Joins Automotive SerDes Alliance to Support ASA-ML Automotive Networking

High-speed communication technologies are becoming increasingly important in modern...

Texas Instruments Uses Agentic AI to Cut MCU Software Migration from Months to Days

Texas Instruments (TI) has upgraded its CCStudio development ecosystem...

Microchip Unveils ATFCD52 for Real-Time Robotic Grip Control and Slip Detection

Reliable robot operation requires more than cameras, especially when...

Keysight Expands High-Power Test Portfolio With New 12 kW DC Power Supplies

Keysight Technologies has expanded its high-power automated test equipment...